Investigating a new biomarker for keratoconus
Utility of PIP as a Novel Keratoconus Biomarker
This study is looking at a protein called PIP to see if it can help doctors spot keratoconus earlier and improve treatment options for people with this eye condition.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of North Texas Hlth Sci Ctr NIH-funded |
| Lab location | 1 site (Fort Worth, United States) |
| Project ID | NIH-10653013 on NIH RePORTER |
What this research studies
This research focuses on keratoconus, a common corneal disorder that can severely impact vision. The study aims to identify prolactin-induced protein (PIP) as a potential biomarker for early diagnosis and treatment of keratoconus. Researchers will analyze PIP levels in various biological fluids, including tears, saliva, and blood, to determine its specificity to keratoconus compared to other diseases. By understanding the role of PIP in keratoconus progression, the research hopes to improve diagnostic methods and treatment options for affected patients.
Who could benefit from this research
Good fit: Ideal candidates for this research are adolescents and young adults aged 12 to 20 who are experiencing symptoms of keratoconus.
Not a fit: Patients with keratoconus who are older than 20 years or those with other unrelated corneal disorders may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier diagnosis and better treatment strategies for patients with keratoconus.
How similar studies have performed: Previous research has shown promising results in identifying biomarkers for other conditions, suggesting potential for success in this novel approach for keratoconus.
Where this research is happening
Fort Worth, United States
- University of North Texas Hlth Sci Ctr — Fort Worth, United States (Active)
Researchers
- Principal investigator: Karamichos, Dimitrios — University of North Texas Hlth Sci Ctr
- Study coordinator: Karamichos, Dimitrios
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.